XML 142 R129.htm IDEA: XBRL DOCUMENT v3.22.4
SEGMENT INFORMATION - Narrative (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2022
Dec. 31, 2022
Salix | Xifaxan Branded Products | Revenue from Contract with Customer, Segment Benchmark | Product Concentration Risk      
Segment reporting information      
Concentration risk, percentage 80.00% 80.00% 80.00%